As per recent reports by Reuters, drugmaker AstraZeneca will resume its coronavirus vaccine’s trial in the US, which was on hold since September.

https://twitter.com/Reuters/status/1319732990356951040

The drugmaker has resumed the trial after approval by the United States regulators, the company said on Friday.

The trial was paused on September 6 after there was a report of a British volunteer who developed a serious neurological illness, believed to be transverse myelitis.

U.S. Health and Human Services Deputy Chief of Staff Paul Mango also told a meeting he was optimistic a U.S. trial by Johnson & Johnson would resume.

The company has been working with Britain’s University of Oxford to develop the vaccine, one of four that started late-stage, Phase 3 trials in the US.